A Quantitative, Cross-Sectional and Observational Study to Characterize Age-Related Structural Changes in Facial Skin of Chinese Women Using Line-Field Confocal Optical Coherence Tomography (LC-OCT)
1 other identifier
observational
100
1 country
1
Brief Summary
This is a single-center, non-interventional, observational, cross-sectional clinical study designed to quantitatively and qualitatively characterize skin properties in a cohort of 100 Chinese female Subjects aged 20 to 70 years. The study involves no product application and poses minimal risk to participants. The primary objectives are to establish a comprehensive skin aging profile database, characterize skin color, aging signs, and biomechanical properties, and create a histomorphometric database for the development and validation of ordinal photographic scales for aging research. Data will be collected through questionnaires, clinical assessments (including LC-OCT imaging), standardized photography, and non-invasive biophysical measurements. All procedures will be conducted in accordance with the ethical principles originating from the Declaration of Helsinki, the International Council for Harmonisation Good Clinical Practice (ICH-GCP) guidelines, and the relevant laws and regulations of China (including the \*Measures for the Ethical Review of Biomedical Research Involving Human Subjects\*). All data will be anonymized and stored securely.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2026
CompletedFirst Submitted
Initial submission to the registry
February 10, 2026
CompletedFirst Posted
Study publicly available on registry
February 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 15, 2027
February 17, 2026
February 1, 2026
12 months
February 10, 2026
February 10, 2026
Conditions
Outcome Measures
Primary Outcomes (8)
Epidermal Thickness
Single visit, day 1
Dermal-Epidermal Junction (DEJ) Undulation Index
Single visit, day 1
Mean Dermal Reflectivity
Single visit, day 1
Stratum Corneum Thickness
Single visit, day 1
Correlation between LC-OCT parameters and chronological age
Single visit, day 1
Skin colorimetric parameter L*a*b*
Single visit, day 1
Correlation between LC-OCT parameters and clinician-graded scores
Single visit, day 1
Correlation between LC-OCT parameters and questionnaire factors
Single visit, day 1
Secondary Outcomes (3)
Clinician-graded score of skin texture/pores
Single visit, day 1
Clinician-graded score of skin pigmentation
Single visit, day 1
Clinician-graded score of facial wrinkles
Single visit, day 1
Study Arms (5)
Group 20 to 29 Years old
Group 30 to 39 Years old
Group 40 to 49 Years old
Group 50 to 59 Years old
Group 60 to 69 Years old
Eligibility Criteria
Approximately 100 healthy Chinese female Subjects, evenly distributed across age groups (20-29, 30-39, 40-49, 50-59, 60-70 years).
You may qualify if:
- Chinese female, aged between 20 and 70 years (inclusive) at the time of signing consent.
- Willing and able to provide written informed consent.
- Fitzpatrick Skin Phototype II or III.
- Willing to comply with all study procedures, including removal of facial makeup and avoidance of intensive skincare (e.g., retinoids, strong acids) on the test areas for 3 days prior to the visit as per instructions.
You may not qualify if:
- Pregnant, planning pregnancy, or breastfeeding (as hormonal changes significantly affect skin properties).
- Presence of temporary tanning, sunburn, or significant erythema on the face or measurement areas.
- Presence of facial piercings, tattoos, too much fluff or significant scarring that would interfere with imaging or measurements in the areas of interest.
- History of any aesthetic or surgical procedure on the face (e.g., laser therapy, chemical peels, injectable fillers, botulinum toxin, plastic surgery) within the past 12 months.
- Current diagnosis or visible signs of a skin disease (e.g., psoriasis, eczema, active acne, rosacea) or a systemic disease known to affect the skin (e.g., diabetes, lupus) on the face or measurement areas.
- Use of systemic medications known to affect skin physiology (e.g., oral retinoids, immunosuppressants, long-term corticosteroids) within the past 3 months, or for a cumulative duration of ≥6 months within the past 2 years.
- Participation in another clinical study on the face or arms within the past 1 month.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ChinaNormlead
Study Sites (1)
HKRI Centre One
Shanghai, Shanghai Municipality, 200072, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 10, 2026
First Posted
February 17, 2026
Study Start
January 15, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
January 15, 2027
Last Updated
February 17, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share